Coston McIsaac & Partners’s Vanguard Health Care ETF VHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18K Hold
60
﹤0.01% 504
2026
Q1
$16K Buy
60
+36
+150% +$10.3K ﹤0.01% 508
2025
Q4
$6K Hold
24
﹤0.01% 645
2025
Q3
$6K Hold
24
﹤0.01% 617
2025
Q2
$5K Hold
24
﹤0.01% 612
2025
Q1
$6K Hold
24
﹤0.01% 576
2024
Q4
$6K Sell
24
-40
-63% -$10.8K ﹤0.01% 570
2024
Q3
$18K Hold
64
0.01% 411
2024
Q2
$17K Hold
64
0.01% 399
2024
Q1
$17K Hold
64
0.01% 407
2023
Q4
$16K Buy
64
+1
+2% +$237 0.01% 417
2023
Q3
$15K Hold
63
0.01% 417
2023
Q2
$15K Hold
63
0.01% 449
2023
Q1
$15K Hold
63
0.01% 445
2022
Q4
$15K Hold
63
0.01% 453
2022
Q3
$14K Hold
63
0.01% 386
2022
Q2
$15K Buy
+63
New +$15.2K 0.01% 243

Other funds holding VHT

Coston McIsaac & Partners's VHT Position: Q2 2026 in Review

Coston McIsaac & Partners held its Vanguard Health Care ETF (VHT) position steady in Q2 2026 at 60 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Coston McIsaac & Partners first reported a position in VHT in Q2 2022 and has held it in 17 quarters since. 1,120 funds tracked by Wall St. Rank hold VHT as of Q2 2026.

  • Coston McIsaac & Partners held 60 shares of Vanguard Health Care ETF worth $18K as of Q2 2026.
  • Coston McIsaac & Partners left its Vanguard Health Care ETF share count unchanged in Q2 2026.
  • Vanguard Health Care ETF made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #504 holding.
  • Coston McIsaac & Partners first reported a position in Vanguard Health Care ETF in Q2 2022 and has held it in 17 quarters since.
  • 1,120 funds tracked by Wall St. Rank held Vanguard Health Care ETF as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.